{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:04:37Z","timestamp":1789603477358,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nonalcoholic fatty liver disease (NAFLD) is a key contributor to chronic liver diseases. It is defined as hepatic fat accumulation in \u2265\u20095% of hepatocytes in individuals with minimal or no alcohol consumption and no other identifiable causes of liver steatosis. Drug-induced hepatic toxicity is increasingly recognized as a key contributor to the development and progression of NAFLD. Among them, valproic acid (VPA), an antiepileptic drug, is well documented for inducing hepatic steatosis, in addition to interfering with folate metabolism and accelerating the progression of NAFLD. The current study distinctively evaluates the protective role of bioactive folate derivatives (folinic acid and 5-methyltetrahydrofolate) in a VPA-induced NAFLD rat model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult female Sprague Dawley rats were divided into three groups: control, diseased and treated. Liver function test, histopathological examination, gene expression analysis, and molecular docking were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Liver function tests indicated that the increase in alanine aminotransferase, alkaline phosphatase, and total bilirubin levels was highly significant in the diseased group, indicative of hepatic injury. Histopathological examination demonstrated severe steatosis in VPA-treated animals, which was significantly improved in the folate-treated group. The NAFLD Activity Score, a mild NAFLD was observed in the diseased group with a total score of 2. Gene expression studies showed high upregulation of HO-1 and pro-inflammatory cytokines TNF-\u03b1 and IL-6 in the diseased group, whereas downregulation was observed in folate-treated rats. Furthermore, molecular docking studies indicated that folinic acid and 5mTHF showed high affinities for binding to KEAP1 protein, suggestive of activation of the Nrf2-KEAP1 antioxidant pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, our data provide significant evidence for the protective potential of bioactive folate supplementation in the amelioration of the VPA-induced liver injury through modulation of oxidative stress, inflammation, and lipid accumulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-026-05047-2","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:31:47Z","timestamp":1782779507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioactive folate attenuates valproic acid-induced NAFLD in female rats"],"prefix":"10.1186","volume":"26","author":[{"given":"Hajra","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Baqir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8864-0250","authenticated-orcid":false,"given":"Naila","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"6","key":"5047_CR1","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Letafatkar N, Norouzi N, et al. Global prevalence of nonalcoholic fatty liver disease: An updated meta-analysis on 78 million population over 38 countries. Arch Med Res. 2024;55(6):103043. https:\/\/doi.org\/10.1016\/j.arcmed.2024.103043.","journal-title":"Arch Med Res"},{"issue":"12","key":"5047_CR2","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/nu16121872","volume":"16","author":"M Yang","year":"2024","unstructured":"Yang M, Wang D, Wang X, et al. Role of folate in liver diseases. Nutrients. 2024;16(12):1872. https:\/\/doi.org\/10.3390\/nu16121872.","journal-title":"Nutrients"},{"issue":"1","key":"5047_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.orcp.2023.01.004","volume":"17","author":"S Yang","year":"2023","unstructured":"Yang S, Ye Z, Liu M, et al. Associations of different serum folate forms with indices of NAFLD and advanced fibrosis. Obes Res Clin Pract. 2023;17(1):58\u201365. https:\/\/doi.org\/10.1016\/j.orcp.2023.01.004.","journal-title":"Obes Res Clin Pract"},{"issue":"1","key":"5047_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41598-024-70481-9","volume":"40","author":"A Hassan","year":"2024","unstructured":"Hassan A, Ahmed T, Hussain M, et al. Prevalence of non-alcoholic fatty liver disease in Pakistan: A population-based study. Pak J Med Sci. 2024;40(1):101\u20137. https:\/\/doi.org\/10.1038\/s41598-024-70481-9.","journal-title":"Pak J Med Sci"},{"issue":"1","key":"5047_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biomedicines10010194","volume":"10","author":"LG Di Pasqua","year":"2022","unstructured":"Di Pasqua LG, Cagna M, Berardo C, Vairetti M, Ferrigno A. Detailed molecular mechanisms involved in drug-induced non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: an update. Biomedicines. 2022;10(1):194. https:\/\/doi.org\/10.3390\/biomedicines10010194.","journal-title":"Biomedicines"},{"key":"5047_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.taap.2017.03.022","volume":"324","author":"X Bai","year":"2017","unstructured":"Bai X, Hong W, Cai P, et al. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol. 2017;324:12\u201325. https:\/\/doi.org\/10.1016\/j.taap.2017.03.022.","journal-title":"Toxicol Appl Pharmacol"},{"key":"5047_CR7","unstructured":"Berli J, Kr\u00e4henb\u00fchl S. Valproic acid and liver injury in patients with epilepsy: An update. Pharmaceutics. 2019."},{"issue":"11","key":"5047_CR8","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.7150\/thno.108593","volume":"15","author":"X He","year":"2025","unstructured":"He X, Yuan R, Chen Y, et al. Mechanism of valproic acid induced hepatic steatosis via enhancing NRF2-FATP2 mediated fatty acid uptake. Theranostics. 2025;15(11):5258\u201376. https:\/\/doi.org\/10.7150\/thno.108593.","journal-title":"Theranostics"},{"issue":"6","key":"5047_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/15376516.2025.2459176","volume":"35","author":"R Kadam","year":"2025","unstructured":"Kadam R, Palkar M, Pingili RB. Mechanisms involved in the valproic acid-induced hepatotoxicity: A comprehensive review. Toxicol Mech Methods. 2025;35(6):565\u201380. https:\/\/doi.org\/10.1080\/15376516.2025.2459176.","journal-title":"Toxicol Mech Methods"},{"key":"5047_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70214","author":"X Liu","year":"2025","unstructured":"Liu X, Li A, Wang J, et al. Acetaminophen aggravates valproate-induced hepatic lipid accumulation and apoptosis by facilitating valproate retention. Br J Pharmacol. 2025. https:\/\/doi.org\/10.1111\/bph.70214.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"5047_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/BF00965336","volume":"11","author":"GF Carl","year":"1986","unstructured":"Carl GF. Effect of chronic valproate treatment on folate-dependent methyl biosynthesis in the rat. Neurochem Res. 1986;11(5):671\u201385. https:\/\/doi.org\/10.1007\/BF00965336.","journal-title":"Neurochem Res"},{"issue":"2","key":"5047_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jcb.21847","volume":"105","author":"M Roy","year":"2008","unstructured":"Roy M, Leclerc D, Wu Q, et al. Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency. J Cell Biochem. 2008;105(2):467\u201376. https:\/\/doi.org\/10.1002\/jcb.21847.","journal-title":"J Cell Biochem"},{"key":"5047_CR13","doi-asserted-by":"publisher","first-page":"1358262","DOI":"10.3389\/fphar.2024.1358262","volume":"15","author":"J Zhu","year":"2024","unstructured":"Zhu J, Wang Z, Sun X, et al. Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients. Front Pharmacol. 2024;15:1358262. https:\/\/doi.org\/10.3389\/fphar.2024.1358262.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5047_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2016","unstructured":"Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2016;25(1):27\u201342. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.009.","journal-title":"Cell Metab"},{"key":"5047_CR15","unstructured":"Khan KM, Jialal I. Folic acid deficiency. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2026 May 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535377\/."},{"key":"5047_CR16","doi-asserted-by":"publisher","first-page":"1272321","DOI":"10.3389\/fnut.2023.1272321","volume":"10","author":"J Li","year":"2023","unstructured":"Li J, Huang J, Lv Y, et al. Association between dietary intakes of B vitamins and nonalcoholic fatty liver disease in postmenopausal women: A cross-sectional study. Front Nutr. 2023;10:1272321. https:\/\/doi.org\/10.3389\/fnut.2023.1272321.","journal-title":"Front Nutr"},{"issue":"2","key":"5047_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/hepr.13828","volume":"53","author":"Z Chen","year":"2023","unstructured":"Chen Z, Yu H, Li Y. Folate deficiency aggravates hepatic steatosis and inflammation in NAFLD models. Hepatol Res. 2023;53(2):215\u201325. https:\/\/doi.org\/10.1111\/hepr.13828.","journal-title":"Hepatol Res"},{"issue":"1","key":"5047_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12915-024-01946-6","volume":"22","author":"WY Chi","year":"2024","unstructured":"Chi WY, Lee GH, Tang MJ, et al. Disturbed intracellular folate homeostasis impairs autophagic flux and increases hepatocytic lipid accumulation. BMC Biol. 2024;22(1):146. https:\/\/doi.org\/10.1186\/s12915-024-01946-6.","journal-title":"BMC Biol"},{"key":"5047_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1743-7075-8-13","volume":"8","author":"Y Nagai","year":"2011","unstructured":"Nagai Y, Miki H, Nakamura A, Ando T, Kumazawa Y, Tsujikawa T, et al. Guava leaf extracts alleviate fatty liver via expression of adiponectin receptors in SHRSP.Z-Leprfa\/Izm rats. Nutr Metab. 2011;8:13. https:\/\/doi.org\/10.1186\/1743-7075-8-13.","journal-title":"Nutr Metabolism"},{"key":"5047_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04798-1","author":"N Shehzadi","year":"2025","unstructured":"Shehzadi N, Ahmad M, Baqir F, et al. Valproic acid-induced placental toxicity: mechanistic insights and the therapeutic potential of bioactive folates. Naunyn Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-04798-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"38","key":"5047_CR21","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.2174\/13816128113199990476","volume":"19","author":"RM Nanau","year":"2013","unstructured":"Nanau RM, Neuman MG. Valproic acid and the liver injury in patients with epilepsy: an update. Curr Pharm Des. 2013;19(38):6662\u201370. https:\/\/doi.org\/10.2174\/13816128113199990476.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"5047_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3109\/00498254.2013.845705","volume":"44","author":"F Scaglione","year":"2014","unstructured":"Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica. 2014;44(5):480\u20138. https:\/\/doi.org\/10.3109\/00498254.2013.845705.","journal-title":"Xenobiotica"},{"issue":"3","key":"5047_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1515\/cclm-2012-0605","volume":"51","author":"R Obeid","year":"2013","unstructured":"Obeid R, Holzgreve W, Pietrzik K. Folate supplementation for prevention of congenital defects and beyond: role of 5-methyltetrahydrofolate. Clin Chem Lab Med. 2013;51(3):475\u201382. https:\/\/doi.org\/10.1515\/cclm-2012-0605.","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"5047_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/tera.1420520509","volume":"52","author":"W Briner","year":"1995","unstructured":"Farinelli E, Giampaoli D, Cenciarini A, Cercado E, Verrotti A. Valproic acid and nonalcoholic fatty liver disease: a possible association? World J Hepatol. 2015;7(9):1251\u20137. https:\/\/doi.org\/10.1002\/tera.1420520509.","journal-title":"Birth Defects Res"},{"issue":"4","key":"5047_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/jn\/129.4.779","volume":"129","author":"LB Bailey","year":"1999","unstructured":"Bailey LB, Gregory JF. Folate metabolism and requirements. J Nutr. 1999;129(4):779\u201382. https:\/\/doi.org\/10.1093\/jn\/129.4.779.","journal-title":"J Nutr"},{"issue":"7","key":"5047_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.pnpbp.2005.06.021","volume":"29","author":"NEW Bottiglieri","year":"2005","unstructured":"Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(7):1103\u201312. https:\/\/doi.org\/10.1016\/j.pnpbp.2005.06.021.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"5047_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3945\/an.111.000992","volume":"3","author":"NEW Crider","year":"2012","unstructured":"Crider KS, Yang KS, Berry TP, R.J. and, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate\u2019s role. Adv Nutr. 2012;3(1):21\u201338. https:\/\/doi.org\/10.3945\/an.111.000992.","journal-title":"Adv Nutr"},{"key":"5047_CR28","doi-asserted-by":"publisher","first-page":"110758","DOI":"10.1016\/j.fct.2019.110758","volume":"133","author":"M Li","year":"2019","unstructured":"Li M, Huang W, Jie F, et al. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking. Food Chem Toxicol. 2019;133:110758. https:\/\/doi.org\/10.1016\/j.fct.2019.110758.","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"5047_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10565-012-9228-8","volume":"28","author":"MR Couto","year":"2012","unstructured":"Couto MR, Gon\u00e7alves P, Catarino T, et al. The effect of oxidative stress upon the intestinal uptake of folic acid: In vitro studies with Caco-2 cells. Cell Biol Toxicol. 2012;28(6):369\u201381. https:\/\/doi.org\/10.1007\/s10565-012-9228-8.","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"5047_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.copbio.2012.08.005","volume":"24","author":"JG LeBlanc","year":"2013","unstructured":"LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Curr Opin Biotechnol. 2013;24(2):160\u20138. https:\/\/doi.org\/10.1016\/j.copbio.2012.08.005.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"5047_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/nu3010118","volume":"3","author":"M Rossi","year":"2011","unstructured":"Rossi M, Amaretti A, Raimondi S. Folate production by probiotic bacteria. Nutrients. 2011;3(1):118\u201334. https:\/\/doi.org\/10.3390\/nu3010118.","journal-title":"Nutrients"},{"issue":"9","key":"5047_CR32","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","volume":"63","author":"H Tilg","year":"2014","unstructured":"Tilg H, Moschen AR. Microbiota and diabetes: An evolving relationship. Gut. 2014;63(9):1513\u201321. https:\/\/doi.org\/10.1136\/gutjnl-2014-306928.","journal-title":"Gut"},{"issue":"4","key":"5047_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41575-020-0266-3","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky J, Vigliotti C, Kaul U, et al. Gut microbiota and non-alcoholic fatty liver disease: Pathophysiology, clinical implications and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2020;17(4):251\u201366. https:\/\/doi.org\/10.1038\/s41575-020-0266-3.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05047-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05047-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05047-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:51:42Z","timestamp":1789602702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05047-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5047"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05047-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The work does not involve any human data. The Institutional Review Board provided approval for animal work according to the ARRIVE guidelines with IRB number (2025-IRB-A74\/74).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"574"}}